AH
Ahmed MD Hamdy
Chief Executive Officer

Ahmed MD Hamdy insider trades: Vincerx Pharma (VINC) stock buys and sales

Chief Executive Officer, Vincerx Pharma Last trade Aug 10, 2023 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2010
3
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ahmed reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 10, 2023VINC↑ Buy$5K
Aug 9, 2023VINC↑ Buy$16K
Dec 14, 2022VINC↑ Buy$31K
Jun 23, 2022VINC↑ Buy$34K
Dec 22, 2021VINC↑ Buy$65K
Jun 29, 2021VINC↑ Buy$100K
Oct 5, 2010PCYC↓ Sell10b5-1$123K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Ahmed MD Hamdy's insider trades

Ahmed MD Hamdy is Chief Executive Officer at Vincerx Pharma (VINC). Since Oct 5, 2010, Ahmed has reported 6 open-market purchases worth $250K and 1 sale worth $123K on SEC Form 4. There have been no open-market trades in the last 12 months.

1 sale (100% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (13 filings), other transactions (3 filings), conversions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VINC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.